Alliance revenue - Koselugo — Milestone payments
Merck & Co. Alliance revenue - Koselugo — Milestone payments remained flat by 0.0% to $18.75M in Q4 2028 compared to the prior quarter. Year-over-year, this metric grew by 50.0%, from $12.50M to $18.75M. Over 3 years (FY 2025 to FY 2028), Alliance revenue - Koselugo — Milestone payments shows a downward trend with a -24.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase signals successful progress in product development or commercialization, while a decrease may indicate delays in meeting project milestones.
Detailed definition
This metric captures revenue recognized upon the achievement of specific, pre-defined events within a collaborative arra...
Peer comparison
Standard in pharmaceutical R&D collaborations where payments are tied to clinical or regulatory success.
mrk_segment_alliance_revenue_koselugo_milestone_paymentsHistorical Data
| FY'25 | FY'26 | FY'27 | FY'28 | |
|---|---|---|---|---|
| Value | $175.00M | $50.00M | $50.00M | $75.00M |
| YoY Change | — | -71.4% | +0.0% | +50.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s alliance revenue - koselugo — milestone payments?
- Merck & Co. (MRK) reported alliance revenue - koselugo — milestone payments of $18.75M in Q4 2028.
- How has Merck & Co.'s alliance revenue - koselugo — milestone payments changed year-over-year?
- Merck & Co.'s alliance revenue - koselugo — milestone payments increased by 50.0% year-over-year, from $12.50M to $18.75M.
- What is the long-term trend for Merck & Co.'s alliance revenue - koselugo — milestone payments?
- Over 3 years (2025 to 2028), Merck & Co.'s alliance revenue - koselugo — milestone payments has grown at a -24.6% compound annual growth rate (CAGR), from $175.00M to $75.00M.
- What does alliance revenue - koselugo — milestone payments mean?
- Revenue earned when specific development or regulatory goals are achieved in a partnership.